Tag Archives: AstraZeneca

Integrating Personalized Medicine into Health Care: PMC/BIO Solutions Summit

PMC/BIO Solutions Summit

While issues in science, regulation and reimbursement are still the focus of most stakeholders in personalized medicine, an increasing number of providers are integrating personalized medicine into the health care system despite obstacles. The 2nd Annual PMC/BIO Solutions Summit will convene representatives from industry, patient groups and payers as well as the increasing number of academic health centers and community health care systems that are already delivering personalized care to discuss those obstacles and, more Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

13 Days Until BIO 2015: Moneyball: Acing the Big Pharma/Small Biotech Deal

BIO Business Networking

In just a few weeks, thousands of players in the pharma and biotech industry will converge on Philadelphia for BIO 2015 seeking knowledge, insight and, for many, the ultimate goal – new partnerships. Collaboration is often the key to success for emerging biotech companies and big pharma alike as it can open the door to new markets, influencers and revenue streams. In oncology, deals between established pharmaceutical companies and early-stage biotechs are especially relevant and Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

The Most Linked In Man in Biotech Retires after 35 Years

Chris Y

The biotech world loses one of its preeminent titans of business development this year with the retirement of Chris Yochim. Variously dubbed “the face of AstraZeneca”, “Mr. Conference”, and other monikers as colorful as his dress shirts, Chris concludes a career spanning 35 years in the pharmaceutical industry. Trained as a pharmacologist, he contributed to the identification of several candidate compounds that are marketed drugs today, but more than anything else, Chris is known as Read More >

Events  |  1 Comment  |  Email This Post
Tags: , , , , , , , ,